logo

Italy Drug Delivery Devices Market Size (2024 - 2029)

The Italian drug delivery devices market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and the development of new drugs and biologics. The market's expansion has been further accelerated by the demand for needles and syringes due to COVID-19 vaccination efforts. The need for effective drug delivery solutions that minimize side effects and enhance treatment efficacy is propelling market growth. Additionally, advancements in technology and increased R&D investment are contributing to the market's development. However, concerns over needlestick injuries pose a challenge to the market's expansion.

Home Market Analysis Healthcare Research Device Drug Combination Research Drug Filled Devices Research Italy Drug Delivery Devices Market Market Size

Market Size of Italy Drug Delivery Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Italy Drug Delivery Devices Market
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 22.40 %

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order
setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Italy Drug Delivery Devices Market Analysis

The Italian drug delivery devices market is expected to register a CAGR of 22.4% over the forecast period.

  • The Italian drug delivery devices market has been significantly impacted by the COVID-19 pandemic because of the development of COVID-19 vaccinations and treatments, which has raised the market's need for needles and syringes for drug delivery devices. For instance, in September 2022, the distribution of Moderna and Pfizer-BioNTech COVID-19 vaccines designed to stop the spread of the Omicron version of the virus was approved by AIFA in Italy.
  • The rising prevalence of chronic diseases and the development of new drugs and biologics are key factors driving the Italian drug delivery devices market growth. Drug delivery devices deliver the drugs that are beneficial for the targeted population to recover fasUsingage of these drug delivery devices reduces the chances of side effects by improving the drug present at the target site. This helps in reducing the dose and associated side effects.
  • In addition, a rising number of chronic diseases like diabetes across the region will promote the adoption of drug-delivery devices and drive the overall market. As per IDF Diabetes Atlas, 2021, the age-adjusted comparative prevalence of diabetes in Italy was estimated as 6.4%, 7.4%, and 8.0% for 2021, 2030, and 2045, respectively. The presence of a huge target population will require regular drug delivery devices for diagnosis and treatment purposes and propel the drug delivery devices market. Similarly, the rising burden of chronic diseases increases the demand for targeted therapy, which is majorly administered through the injectable route of administration. Moreover, increasing R&D expenditure by innovators and market players and technological advancements in understanding human biology and diseases will fuel the overall market.
  • However, the risk of needlestick injuries is restraining the growth of the Italian drug delivery devices market.

Italy Drug Delivery Devices Industry Segmentation

As specified in the scope, drug delivery devices or systems are the tools used to deliver the drug through the specific route of administration. It enables the introduction of therapeutic substances in the body. 

The Italian drug delivery devices market is expected to register a CAGR of 22.4% over the forecast period. The Italian drug delivery devices market is segmented by route of administration (injectable, topical, ocular, and other routes of administration), application (cancer, cardiovascular, diabetes, infectious diseases, and other applications), and end user (hospitals, ambulatory surgical centers, and other end users). The report offers the value (in USD million) for the above segments.

By Route of Administration
Injectable
Topical
Ocular
Other Routes of Administration
By Application
Cancer
Cardiovascular
Diabetes
Infectious Diseases
Other Applications
By End User
Hospitals
Ambulatory Surgical Centers
Other End Users
Need A Different Region Or Segment?
Customize Now

Italy Drug Delivery Devices Market Size Summary

The Italian drug delivery devices market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and the development of new drugs and biologics. The market has experienced a significant boost due to the COVID-19 pandemic, which heightened the demand for needles and syringes used in drug delivery devices. The rising incidence of chronic conditions such as diabetes necessitates the use of these devices for effective diagnosis and treatment, thereby propelling market expansion. Technological advancements and increased research and development investments by key players further contribute to the market's growth trajectory. However, the risk of needlestick injuries presents a challenge to market expansion.

The injectable drug delivery segment is expected to witness significant growth, fueled by the convenience and immediate action it offers. Innovations in the prevention and treatment of chronic diseases, such as the development of a cancer vaccine by an Italian research team, underscore the need for advanced drug delivery devices. Collaborations among major industry players, like the partnership between Stevanato Group SpA and Bexson Biomedical Inc., are set to enhance the market landscape. The rising burden of infectious diseases in Italy also drives demand for various drug delivery devices, particularly for vaccinations. The market is moderately competitive, with major companies like Pfizer Inc., Novartis AG, and Johnson & Johnson Services Inc. leading the charge, and recent developments such as the Ready-To-Use solution platform by Stevanato Group SpA and Gerresheimer AG highlight ongoing innovation in the sector.

Explore More

Italy Drug Delivery Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Prevalence of Chronic Diseases

      2. 1.2.2 Technological Advancements Coupled with Rapidly Growing Biologics Market

    3. 1.3 Market Restraints

      1. 1.3.1 Risk of Needlestick Injuries

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Route of Administration

      1. 2.1.1 Injectable

      2. 2.1.2 Topical

      3. 2.1.3 Ocular

      4. 2.1.4 Other Routes of Administration

    2. 2.2 By Application

      1. 2.2.1 Cancer

      2. 2.2.2 Cardiovascular

      3. 2.2.3 Diabetes

      4. 2.2.4 Infectious Diseases

      5. 2.2.5 Other Applications

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Ambulatory Surgical Centers

      3. 2.3.3 Other End Users

Italy Drug Delivery Devices Market Size FAQs

The Italy Drug Delivery Devices Market is projected to register a CAGR of 22.40% during the forecast period (2024-2029)

Gerresheimer AG, Teva Pharmaceutical Industries Ltd, Viatris Inc, Baxter and BD (Becton, Dickinson and Company) are the major companies operating in the Italy Drug Delivery Devices Market.

Italy Drug Delivery Devices Report Snapshots

Italy Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)